Hartford Healthcare R5 (HGHTX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD

50.64

-0.06 (-0.12%)

At close: Oct 2, 2026

Fund Assets	806.48M
Expense Ratio	1.06%
Min. Investment	$0.00
Turnover	40.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 11, 2025

Previous Close	50.70
YTD Return	5.92%
1-Year Return	18.96%
5-Year Return	17.32%
52-Week Low	43.82
52-Week High	54.75
Beta (5Y)	0.84
Holdings	84
Inception Date	Dec 22, 2006

About HGHTX

The Hartford Mutual Funds, Inc. Hartford Healthcare Fund Class R5 is an open-end mutual fund specializing in the global healthcare sector. Its primary objective is to achieve long-term capital appreciation by investing at least 80% of its assets in equity securities of healthcare-related companies worldwide. Managed jointly by Hartford Funds Management Company, LLC and Wellington Management Company LLP, the fund takes a diversified approach, targeting industries such as pharmaceuticals, biotechnology, medical devices, health information services, and emerging healthcare subsectors. This fund employs fundamental analysis to select both growth and value stocks across large, mid, and small capitalizations. With over 100 holdings and a significant portion of assets allocated to its top holdings, it aims to capture opportunities across the rapidly evolving healthcare landscape. The fund serves investors seeking exposure to the innovations and defensive qualities characteristic of the healthcare industry, benchmarking its performance against indices like the S&P Composite 1500 Health Care Index and the S&P 500 Index. It is notable for its broad sector coverage and global investment mandate.

Fund Family Hartford Mutual Funds

Category Health

Performance Rating Average

Risk Rating Average

Stock Exchange Nasdaq

Ticker Symbol HGHTX

Share Class Class R5

Index S&P Composite 1500 Health Care TR

Performance

HGHTX had a total return of 18.96% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.87%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
HGHVX	Class R6	0.94%
HGHFX	Class F	0.94%
HGHIX	Class I	1.05%
HGHYX	Class Y	1.05%

Top 10 Holdings

47.62% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	12.03%
Johnson & Johnson	JNJ	6.74%
Merck & Co., Inc.	MRK	5.99%
UnitedHealth Group Incorporated	UNH	4.73%
AbbVie Inc.	ABBV	4.21%
Elevance Health, Inc.	ELV	3.00%
Intuitive Surgical, Inc.	ISRG	2.87%
CVS Health Corporation	CVS	2.84%
Vertex Pharmaceuticals Incorporated	VRTX	2.64%
Danaher Corporation	DHR	2.57%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 11, 2025	$1.40315	Dec 12, 2025
Dec 27, 2024	$0.07368	Dec 30, 2024
Dec 11, 2024	$1.89862	Dec 12, 2024
Dec 12, 2022	$0.36137	Dec 13, 2022
Dec 10, 2021	$4.37361	Dec 13, 2021
Dec 10, 2020	$5.16605	Dec 11, 2020

Full Dividend History